Among these, ‘proteoglycans in cancer’ (P = 0.0040) and ‘NF-kappa B signaling pathway’ (P = 0.0316), involving TLR2, TLR4 and IL-12B genes, were our main focus due to their roles in immunity response. This evidence concerns the gene IL12B and cancer.